Neuroinflammation in Alzheimer's Disease

Overview

Journal Neuropsychiatr Dis Treat

Publisher Dove Medical Press

Specialty Psychiatry

Date 2015 Feb 13

PMID 25673992

Citations 115

Authors

Fengjin Zhang

Linlan Jiang

Affiliations

Soon will be listed here.

Abstract

Amyloid-β plaques and neurofibrillary tangles are the main neuropathological hallmarks in Alzheimer's disease (AD), the most common cause of dementia in the elderly. However, it has become increasingly apparent that neuroinflammation plays a significant role in the pathophysiology of AD. This review summarizes the current status of neuroinflammation research related to AD, focusing on the connections between neuroinflammation and some inflammation factors in AD. Among these connections, we discuss the dysfunctional blood-brain barrier and alterations in the functional responses of microglia and astrocytes in this process. In addition, we summarize and discuss the role of intracellular signaling pathways involved in inflammatory responses in astrocytes and microglia, including the mitogen-activated protein kinase pathways, nuclear factor-kappa B cascade, and peroxisome proliferator-activated receptor-gamma transcription factors. Finally, the dysregulation of the control and release of pro- and anti-inflammatory cytokines and classic AD pathology (amyloid plaques and neurofibrillary tangles) in AD is also reviewed.

Citing Articles

Heterogeneous treatment effects of BCG vaccine on Alzheimer's disease risk.

Chaudhuri I, Das S J Alzheimers Dis Rep. 2025; 9:25424823251317955.

PMID: 40034522 PMC: 11864241. DOI: 10.1177/25424823251317955.

The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects.

Karati D, Mukherjee S, Roy S Toxicol Rep. 2025; 14:101945.

PMID: 39996037 PMC: 11848497. DOI: 10.1016/j.toxrep.2025.101945.

Inhibition of the Transforming Growth Factor-β Signaling Pathway Confers Neuroprotective Effects on Beta-Amyloid-Induced Direct Neurotoxicity and Microglia-Mediated Neuroinflammation.

Tiong S, Mohgan R, Quek J, Liew J, Wong G, Thang Z Neurol Res Int. 2025; 2025:8948290.

PMID: 39949498 PMC: 11824711. DOI: 10.1155/nri/8948290.

Advances in the Regulation of Inflammatory Mediators in Nitric Oxide Synthase: Implications for Disease Modulation and Therapeutic Approaches.

Kim M, Lee J Int J Mol Sci. 2025; 26(3).

PMID: 39940974 PMC: 11818275. DOI: 10.3390/ijms26031204.

Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease-A Review.

Moradi F, Mokhtari T J Biochem Mol Toxicol. 2025; 39(2):e70071.

PMID: 39853846 PMC: 11798427. DOI: 10.1002/jbt.70071.

References

Rivest S, Lacroix S, Vallieres L, Nadeau S, Zhang J, Laflamme N . How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med. 2000; 223(1):22-38. DOI: 10.1046/j.1525-1373.2000.22304.x. View

de la Monte S, Wands J . Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis. 2006; 9(2):167-81. DOI: 10.3233/jad-2006-9209. View

Griffin W, Liu L, Li Y, Mrak R, Barger S . Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation. 2006; 3:5. PMC: 1435743. DOI: 10.1186/1742-2094-3-5. View

Querfurth H, LaFerla F . Alzheimer's disease. N Engl J Med. 2010; 362(4):329-44. DOI: 10.1056/NEJMra0909142. View

Martinez-Canabal A, Wheeler A, Sarkis D, Lerch J, Lu W, Buckwalter M . Chronic over-expression of TGFβ1 alters hippocampal structure and causes learning deficits. Hippocampus. 2013; 23(12):1198-211. DOI: 10.1002/hipo.22159. View

Uslu S, Akarkarasu Z, Ozbabalik D, Ozkan S, Colak O, Demirkan E . Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia. Neurochem Res. 2012; 37(7):1554-9. DOI: 10.1007/s11064-012-0750-0. View

Takeda S, Sato N, Ikimura K, Nishino H, Rakugi H, Morishita R . Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol Aging. 2013; 34(8):2064-70. DOI: 10.1016/j.neurobiolaging.2013.02.010. View

Sun D, Jakobs T . Structural remodeling of astrocytes in the injured CNS. Neuroscientist. 2011; 18(6):567-88. PMC: 3713769. DOI: 10.1177/1073858411423441. View

Bhat R, Crowe E, Bitto A, Moh M, Katsetos C, Garcia F . Astrocyte senescence as a component of Alzheimer's disease. PLoS One. 2012; 7(9):e45069. PMC: 3440417. DOI: 10.1371/journal.pone.0045069. View

10.

Heneka M, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C . Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain. 2005; 128(Pt 6):1442-53. DOI: 10.1093/brain/awh452. View

11.

Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P . Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol Sci. 2006; 27(1):33-9. DOI: 10.1007/s10072-006-0562-6. View

12.

Arima Y, Kamimura D, Sabharwal L, Yamada M, Bando H, Ogura H . Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory. Mediators Inflamm. 2013; 2013:898165. PMC: 3748732. DOI: 10.1155/2013/898165. View

13.

Czeh M, Gressens P, Kaindl A . The yin and yang of microglia. Dev Neurosci. 2011; 33(3-4):199-209. DOI: 10.1159/000328989. View

14.

Joseph-Mathurin N, Dorieux O, Trouche S, Boutajangout A, Kraska A, Fontes P . Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds. Neurobiol Aging. 2013; 34(11):2613-22. PMC: 4107237. DOI: 10.1016/j.neurobiolaging.2013.05.013. View

15.

Qin H, Benveniste E . ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro. Methods Mol Biol. 2011; 814:235-49. DOI: 10.1007/978-1-61779-452-0_16. View

16.

Kornman K . Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr. 2006; 83(2):475S-483S. DOI: 10.1093/ajcn/83.2.475S. View

17.

Citron M . Alzheimer's disease: strategies for disease modification. Nat Rev Drug Discov. 2010; 9(5):387-98. DOI: 10.1038/nrd2896. View

18.

Kersten S . Peroxisome proliferator activated receptors and lipoprotein metabolism. PPAR Res. 2008; 2008:132960. PMC: 2220040. DOI: 10.1155/2008/132960. View

19.

Floden A, Combs C . Microglia demonstrate age-dependent interaction with amyloid-β fibrils. J Alzheimers Dis. 2011; 25(2):279-93. PMC: 3295838. DOI: 10.3233/JAD-2011-101014. View

20.

Weiss R, Lifshitz V, Frenkel D . TGF-β1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis. Brain Behav Immun. 2010; 25(5):1017-24. DOI: 10.1016/j.bbi.2010.11.012. View